Omicron Variant-Specific Serological Imprinting Following BA.1 or BA.4/5 Bivalent Vaccination and Previous SARS-CoV-2 Infection: A Cohort Study

BACKGROUND: Continuous evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) outpaces monovalent vaccine cross-protection to new viral variants. Consequently, bivalent coronavirus disease 2019 (COVID-19) vaccines including Omicron antigens were developed. The contrasting immunoge...

Descripción completa

Detalles Bibliográficos
Autores principales: Baerends, Eva A M, Reekie, Joanne, Andreasen, Signe R, Stærke, Nina B, Raben, Dorthe, Nielsen, Henrik, Petersen, Kristine T, Johansen, Isik S, Lindvig, Susan O, Madsen, Lone W, Wiese, Lothar, Iversen, Mette B, Benfield, Thomas, Iversen, Kasper K, Larsen, Fredrikke D, Andersen, Sidsel D, Juhl, Anna K, Dietz, Lisa L, Hvidt, Astrid K, Ostrowski, Sisse R, Krause, Tyra G, Østergaard, Lars, Søgaard, Ole S, Lundgren, Jens, Tolstrup, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10686961/
https://www.ncbi.nlm.nih.gov/pubmed/37392436
http://dx.doi.org/10.1093/cid/ciad402

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10686961/
https://www.ncbi.nlm.nih.gov/pubmed/37392436
http://dx.doi.org/10.1093/cid/ciad402

Ejemplares similares